Evidence map›Paper›PMID 29452580›Full record

ReviewRetrovirology2018

Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained.

Marilia Rita Pinzone, Una O'Doherty

Open access · goldAbstract readReview
In one paragraph

Review in Retrovirology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. HIV Reservoir: How to Measure It?Current HIV/AIDS reports · 2023
    Review
  3. How CD4Biomedicines · 2023
    Article
  4. HTLV-2 Enhances CD8Viruses · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Targeting HIV-1 proviral transcription.Current opinion in virology · 2019
    Review
  12. Review
  13. Of HIV and men.Journal of virus eradication · 2019
    Article
  14. Article
  15. Review
  16. CD4AIDS research and human retroviruses · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Marilia Rita PinzoneDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Una O'DohertyDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA. unao@pennmedicine.upenn.edu.
University of Pennsylvania · US

Funding

BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral EradicationUM1AI126617 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI JONES, R. BRAD, NIXON, DOUGLAS F · 2016 to 2020
$28.1M
A FAST Assay to Quantify HIV ReservoirsR01AI120011 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI O'DOHERTY, UNA T, SAMBUCETTI, LIDIA C · 2015 to 2019
$3.1M
Targeting the Persistent HIV-1 Viral Reservoir Using Engineered T cellsR33AI104280 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI RILEY, JAMES L. · 2015 to 2017
$1.4M
NIAID NIH HHS R01 AI120011NIAID NIH HHS R33 AI104280NIAID NIH HHS UM1 AI126617NIH HHS R01-AI-120011NIH HHS R33-AI-104280NIH HHS UM1-AI-126617
6 · The paper itself

Abstract

The identification of the most appropriate marker to measure reservoir size has been a great challenge for the HIV field. Quantitative viral outgrowth assay (QVOA), the reference standard to quantify the amount of replication-competent virus, has several limitations, as it is laborious, expensive, and unable to robustly reactivate every single integrated provirus. PCR-based assays have been developed as an easier, cheaper and less error-prone alternative to QVOA, but also have limitations. Historically, measuring integrated HIV DNA has provided insights about how reservoirs are formed and maintained. In the 1990s, measuring integrated HIV DNA was instrumental in understanding that a subset of resting CD4 T cells containing integrated HIV DNA were the major source of replication-competent virus. Follow-up studies have further characterized the phenotype of these cells containing integrated HIV DNA, as well as shown the correlation between the integration levels and clinical parameters, such as duration of infection, CD4 count and viral load. Integrated HIV DNA correlates with total HIV measures and with QVOA. The integration assay has several limitations. First, it largely overestimates the reservoir size, as both defective and replication-competent proviruses are detected. Since defective proviruses are the majority in patients on ART, it follows that the number of proviruses capable of reactivating and releasing new virions is significantly smaller than the number of integrated proviruses. Second, in patients on ART clonal expansion could theoretically lead to the preferential amplification of proviruses close to an Alu sequence though longitudinal studies have not captured this effect. Proviral sequencing combined with integration measures is probably the best estimate of reservoir size, but it is expensive, time-consuming and requires considerable bioinformatics expertise. All these reasons limit its use on a large scale. Herein, we review the utility of measuring HIV integration and suggest combining it with sequencing and total HIV measurements can provide insights that underlie reservoir maintenance.

Indexed as

Viral LoadVirus IntegrationVirus LatencyAcute DiseaseCD4-Positive T-LymphocytesChronic DiseaseDisease ReservoirsHIV-1HIV InfectionsHumansPolymerase Chain ReactionProvirusesVirus ReplicationARTHIVIntegrated HIV DNAProviral DNAReservoirSequencing

Identifiers

PMID29452580
PMCPMC5816390
OpenAlexW2800927670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.